• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Matrilin-4 (MATN4)

ACP20660

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP20660 Target NameMATN4
Target SynonymsFLJ14417; HE6WCR54; Matn4; MATN4_HUMAN; Matrilin-4FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range19-622
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO95460
Background Information
  • Uniprot Id

    O95460

  • Target Species

    Human

  • Target Name

    MATN4

  • Target Full Name

    Matrilin-4

  • Target Function

    Major component of the extracellular matrix of cartilage.

  • Target Subcellular Location

    Secreted.

  • Target Tissue Specificity

    Embryonic kidney, lung and placenta.

  • Target Synonyms

    FLJ14417; HE6WCR54; Matn4; MATN4_HUMAN; Matrilin-4

  • Target Background

    This gene encodes a member of von Willebrand factor A domain-containing protein family. The proteins of this family are thought to be involved in the formation of filamentous networks in the extracellular matrices of various tissues. This family member is thought to be play a role in reorganizing and regenerating the corneal matrix in granular and lattice type I dystrophies. It may also be involved in wound healing in the dentin-pulp complex. Alternative splicing results in multiple transcript variants.

Inquire Recombinant Human Matrilin-4 (MATN4) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification